Efficacy and Safety of Apatinib in Relapsed or Refractory Diffuse Large B Cell Lymphoma: An Open-Label, Single-Arm, Prospective Study

被引：0
|
作者：
Ma, Xinran [1 ]
Li, Ling [1 ]
Zhang, Lei [1 ]
Li, Xin [1 ]
Fu, Xiaorui [1 ]
Wang, Xinhua [1 ]
Wu, Jingjing [1 ]
Zhang, Xudong [1 ]
Feng, Xiaoyan [1 ]
Zhou, Zhiyuan [1 ]
Chang, Yu [1 ]
Li, Zhaoming [1 ]
Young, Ken H. [2 ]
Zhang, Mingzhi [1 ]
机构：
[1] Zhengzhou Univ, Dept Oncol, Affiliated Hosp 1, Zhengzhou, Peoples R China
[2] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-127912
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2873
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Apatinib in Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma: A Phase II, Open-Label, Single-Arm, Prospective Study
    Ma, Xinran
    Li, Ling
    Zhang, Lei
    Fu, Xiaorui
    Li, Xin
    Wang, Xinhua
    Wu, Jingjing
    Sun, Zhenchang
    Zhang, Xudong
    Feng, Xiaoyan
    Chang, Yu
    Zhou, Zhiyuan
    Nan, Feifei
    Zhang, Jieming
    Li, Zhaoming
    Zhang, Mingzhi
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2020, 14 : 275 - 284
  • [2] Efficacy and Safety of Lenalidomide, PD-1 Monoclonal Antibodies Combined with Orelabrutinib in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Multicenter, Open-Label, Single-Arm, Phase II Study
    Wang, Lingling
    Huang, Yongfen
    Chen, Hui
    Xu, Hao
    Cheng, Yuexin
    Miao, Yuqing
    BLOOD, 2024, 144 : 6488 - 6489
  • [3] Loncastuximab tesirine in Chinese patients with relapsed or refractory diffuse large B-cell lymphoma: a multicenter, open-label, single-arm, phase II trial
    Lin, Ningjing
    Sun, Xiuhua
    Zhou, Hui
    Zou, Liqun
    Zhou, Keshu
    Liu, Lihong
    Yang, Haiyan
    Hu, Kai
    Cai, Qingqing
    Liu, Yao
    Jin, Jie
    Zhang, Liling
    Li, Wenyu
    Guo, Ye
    Yang, Wei
    Luo, Feng
    Wang, Zhenguang
    Zhu, Rong
    Yang, Lei
    Song, Dan
    Song, Yuqin
    Zhu, Jun
    HAEMATOLOGICA, 2025, 110 (03) : 683 - 692
  • [4] Single arm phase II open label study of thalidomide in patients with refractory or relapsed diffuse large B cell lymphoma
    Hatton, C. S. R.
    Peniket, A.
    Tusold, A.
    Collins, G. P.
    Joyner, M.
    Lee, R.
    Mouncey, P.
    Smith, P.
    Lee, S-M
    BRITISH JOURNAL OF HAEMATOLOGY, 2009, 145 : 13 - 13
  • [5] Loncastuximab tesirine in relapsed or refractory diffuse large B-cell lymphoma (LOTIS-2): a multicentre, open-label, single-arm, phase 2 trial
    Caimi, Paolo F.
    Ai, Weiyun
    Alderuccio, Juan Pablo
    Ardeshna, Kirit M.
    Hamadani, Mehdi
    Hess, Brian
    Kahl, Brad S.
    Radford, John
    Solh, Melhem
    Stathis, Anastasios
    Zinzani, Pier Luigi
    Havenith, Karin
    Feingold, Jay
    He, Shui
    Qin, Yajuan
    Ungar, David
    Zhang, Xiaoyan
    Carlo-Stella, Carmelo
    LANCET ONCOLOGY, 2021, 22 (06): : 790 - 800
  • [6] Open-Label, Single-Arm, Phase II Study of Everolimus in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma
    Johnston, Patrick B.
    Pinter-Brown, Lauren
    Rogerio, Jaqueline
    Warsi, Ghulam
    Graham, Anne
    Ramchandren, Radhakrishnan
    BLOOD, 2011, 118 (21) : 1169 - 1169
  • [7] Everolimus for Relapsed/Refractory Classical Hodgkin Lymphoma: Multicenter, Open-Label, Single-Arm, Phase 2 Study
    Johnston, Patrick B.
    Pinter-Brown, Lauren
    Rogerio, Jaqueline
    Warsi, Ghulam
    Chau, Quincy
    Ramchandren, Radhakrishnan
    BLOOD, 2012, 120 (21)
  • [8] An open-label, single-center, phase II, single-arm trial of camrelizumab combined with apatinib in patients with relapsed or refractory peripheral T-cell lymphoma
    Xie, Y.
    Mi, L.
    Zheng, W.
    Ping, L.
    Lin, N.
    Tu, M.
    Zhang, C.
    Ying, Z.
    Liu, W.
    Deng, L.
    Wu, M.
    Wang, X.
    Zhu, J.
    Song, Y.
    ANNALS OF ONCOLOGY, 2020, 31 : S652 - S652
  • [9] Efficacy and safety of minocycline in retinitis pigmentosa: a prospective, open-label, single-arm trial
    Chen, Yuxi
    Pan, Yuan
    Xie, Yanyan
    Shi, Yuxun
    Lu, Yao
    Xia, Yiwen
    Su, Wenru
    Chen, Xiaoqing
    Li, Zuoyi
    Wang, Minzhen
    Miao, Siyu
    Yang, Yating
    Jin, Chenjin
    Luo, Guangwei
    Long, Shixian
    Xiao, Hui
    Huang, Chuangxin
    Zhang, Jian
    Liang, Dan
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2024, 9 (01)
  • [10] Safety and Efficacy of Apatinib Monotherapy for Unresectable, Metastatic Esophageal Cancer: A Single-Arm, Open-Label, Phase II Study
    Li Yanwei
    Feng, He
    Ren, Peng
    Yue, Jie
    Zhang, Wencheng
    Tang, Peng
    Shang, Xiaobin
    Pang, Qingsong
    Liu, Dongying
    Chen, Chuangui
    Pan, Zhanyu
    Tao, Yu Zhen
    ONCOLOGIST, 2020, 25 (10): : E1464 - E1472
12345